Marketing-authorisation holder · Canada
Mylan Pharmaceuticals Ulc
608 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
608 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 608
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CAMPRAL333 mg · Tablet (Delayed-Release) | Acamprosate | Canada | Marketed | 2007 |
| CLARUS10 mg · Capsule | Isotretinoin | Canada | Marketed | 2005 |
| CLARUS40 mg · Capsule | Isotretinoin | Canada | Marketed | 2005 |
| GEN-CLOZAPINE12.5 mg · Tablet (Orally-Disintegrating) | Clozapine | Canada | Marketed | 2025 |
| GEN-CLOZAPINE25 mg · Tablet | Clozapine | Canada | Marketed | 2003 |
| GEN-CLOZAPINE200 mg · Tablet | Clozapine | Canada | Marketed | 2008 |
| GEN-CLOZAPINE50 mg · Tablet (Orally-Disintegrating) | Clozapine | Canada | Marketed | 2025 |
| GEN-CLOZAPINE100 mg · Tablet (Orally-Disintegrating) | Clozapine | Canada | Marketed | 2025 |
| GEN-CLOZAPINE100 mg · Tablet | Clozapine | Canada | Marketed | 2003 |
| GEN-CLOZAPINE200 mg · Tablet (Orally-Disintegrating) | Clozapine | Canada | Marketed | 2025 |
| GEN-CLOZAPINE25 mg · Tablet (Orally-Disintegrating) | Clozapine | Canada | Marketed | 2025 |
| GEN-CLOZAPINE50 mg · Tablet | Clozapine | Canada | Marketed | 2008 |
| GLATIRAMER ACETATE INJECTION20 mg / ml · Solution | Glatiramer acetate | Canada | Marketed | 2024 |
| MYL-ESOMEPRAZOLE40 mg · Tablet (Delayed-Release) | Esomeprazole | Canada | Marketed | 2020 |
| MYL-ESOMEPRAZOLE20 mg · Tablet (Delayed-Release) | Esomeprazole | Canada | Marketed | 2020 |
| MYLAN-ABACAVIR/LAMIVUDINE600 mg + 300 mg · Tablet | Abacavir, Lamivudine | Canada | Marketed | 2016 |
| MYLAN-ACYCLOVIR400 mg · Tablet | Aciclovir | Canada | Marketed | 2000 |
| MYLAN-ACYCLOVIR200 mg · Tablet | Aciclovir | Canada | Marketed | 2000 |
| MYLAN-ACYCLOVIR800 mg · Tablet | Aciclovir | Canada | Marketed | 2000 |
| MYLAN-ALMOTRIPTAN12.5 mg · Tablet | Almotriptan | Canada | Marketed | 2013 |
| MYLAN-ALMOTRIPTAN6.25 mg · Tablet | Almotriptan | Canada | Marketed | 2013 |
| MYLAN-AMLODIPINE10.0 mg · Tablet | Amlodipine | Canada | Marketed | 2009 |
| MYLAN-AMLODIPINE5.0 mg · Tablet | Amlodipine | Canada | Marketed | 2009 |
| MYLAN-AMLODIPINE/ATORVASTATIN5 mg + 10 mg · Tablet | Amlodipine, Atorvastatin | Canada | Marketed | 2011 |
| MYLAN-AMLODIPINE/ATORVASTATIN10 mg + 40 mg · Tablet | Amlodipine, Atorvastatin | Canada | Marketed | 2011 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 608 | 135 | 473 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.